COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 1020: Articles 10191-10200  | Next

Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021
Backer, J. A., Eggink, D., Andeweg, S. P., Veldhuijzen, I. K., van Maarseveen, N., Vermaas, K., Vlaemynck, B., Schepers, R., van den Hof, S., Reusken, C., Wallinga, J.
10.1101/2022.01.18.22269217 — Posted: 2022-01-23
ESTIMATING THE EFFECT OF VACCINATION ON THE CASE-FATALITY RATE FOR COVID-19
Murata, G. H., Murata, A. E., Campbell, H. M., Mao, J. T.
10.1101/2022.01.22.22269689 — Posted: 2022-01-23
Risk of COVID-19 Reinfection and Vaccine Breakthrough Infection, Madera County, California, 2021
Nguyen, M., Paul, E., Mills, P. K., Paul, S.
10.1101/2022.01.22.22269105 — Posted: 2022-01-23
Evaluation of the effects of vaccination regimes on the transmission dynamics of COVID-19 pandemic
Nakamoto, I.
10.1101/2022.01.22.22269569 — Posted: 2022-01-23
Beyond vaccination: A Cross-Sectional Study of the importance of Behavioral and Native Factors on COVID-19 Infection and Severity.
Aouissi, H. A., Ababsa, M., Leveau, C., Petrisor, A.-I., Slomka, A., Yasuhara, J., Epelboin, L., Ohmagari, N.
10.1101/2022.01.23.22269214 — Posted: 2022-01-23
PRICE COVID19 Data Report December 2021 Pakistan Registry of Intensive Care
farooq, A., Arsalan, R., Aisha, M. K., Muhammad, A., Hayat, M., Altaf, A., Taqi, A., Kumar, A., Rehman, A., Haidri, F. R., Hussain, I., Chaudhry, M., Rehman, S., Malik, I., Saleem, J., Ali, L., Zia, M. A., Khan, M. A., Sheikh, M., Ashraf, M. S., Rana, M. A., Khoso, M. N., Rizvi, S., Shaikh, N. A., Salahuddin, N., Khan, Q.-u.-A., Sikander, R. I., Ali, S. M., Khan, R. N., Babar, S., Beane, A., Dondorp, A. M., Kodippily, C., Priyadarshani, D., Udayanga, I., Ishani, P., Darshana, S., Rashan, T., Haniffa, R., Murthy, S., Hashmi, M.
10.1101/2022.01.20.22269202 — Posted: 2022-01-23
Social isolation during the COVID-19 pandemic in Spain: a population study
Martinez Garcia, M., Sansano Sansano, E., Castillo Hornero, A., Femenia, R., Roomp, K., Oliver, N.
10.1101/2022.01.22.22269682 — Posted: 2022-01-23
Modelling Quarantine Effects on SARS-CoV-2 Epidemiological Dynamics in Chilean Communes and their Relationship with the Social Priority Index
Salinas, D. G., Bustamante, M. L., Gallardo, M. O.
10.1101/2022.01.21.22269658 — Posted: 2022-01-23
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
Maeda, H., Saito, N., Igarashi, A., Ishida, M., Suami, K., Yagiuchi, A., Kimura, Y., Komino, M., Arai, H., Morikawa, T., Motohashi, I., Miyazawa, R., Moriyama, T., Kamura, H., Terada, M., Kuwamitsu, O., Hayakawa, T., Sando, E., Ohara, Y., Teshigawara, O., Suzuki, M., Morimoto, K.
10.1101/2022.01.17.22269394 — Posted: 2022-01-23
Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review
Perry, J. A., Osman, S., Wright, J., Richard-Greenblatt, M., Buchan, S. A., Sadarangani, M., Bolotin, S.
10.1101/2022.01.21.22269667 — Posted: 2022-01-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).